D'Amico Prostate Cancer Risk Classification

Classify localised prostate cancer as Low, Intermediate, or High risk using PSA, Gleason score, and clinical stage. Low: PSA < 10 + GS <= 6 + stage <= T2a. High: PSA > 20 or GS >= 8 or stage >= T2c.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Classify localised prostate cancer as Low, Intermediate, or High risk using PSA, Gleason score, and clinical stage. Low: PSA < 10 + GS <= 6 + stage <= T2a. High: PSA > 20 or GS >= 8 or stage >= T2c

Each component has a specific meaning:

  • PSA — The psa recorded for the scenario being assessed.
  • Clinical stage — The clinical stage recorded for the scenario being assessed.

Note: Interpret the d'amico risk result against the thresholds and context described above.

How to Use

Enter the PSA, clinical stage for the scenario you are assessing. Classify localised prostate cancer as Low, Intermediate, or High risk using PSA, Gleason score, and clinical stage. Low: PSA < 10 + GS <= 6 + stage <= T2a. High: PSA > 20 or GS >= 8 or stage >= T2c. Use the d'amico risk result to inform your calculation.

Related Calculators

CAPRA Score

Medical

Gleason Grade Group

Medical

PSA Doubling Time

Medical

Frequently Asked Questions